Guided Therapeutics Inc. (OTCMKTS:GTHP – Get Free Report)’s stock price was up 25.6% during trading on Monday . The stock traded as high as $0.25 and last traded at $0.2010. Approximately 3,114 shares were traded during trading, a decline of 76% from the average daily volume of 13,128 shares. The stock had previously closed at $0.16.
Guided Therapeutics Trading Up 25.6%
The firm has a market capitalization of $16.80 million, a price-to-earnings ratio of -4.02 and a beta of 0.38. The firm’s 50-day moving average is $0.25 and its 200 day moving average is $0.22.
Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) last announced its quarterly earnings results on Thursday, November 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.06 million for the quarter.
About Guided Therapeutics
Guided Therapeutics, Inc, a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light.
Featured Stories
- Five stocks we like better than Guided Therapeutics
- What Are the FAANG Stocks and Are They Good Investments?
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- How to Use Stock Screeners to Find Stocks
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- Investing In Preferred Stock vs. Common Stock
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for Guided Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guided Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
